The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000763347p
Ethics application status
Help: Ethics application status
Submitted, not yet approved
Date submitted
Help: Date submitted
31/05/2026
Date registered
Help: Date registered
26/06/2026
Date last updated
Help: Date last updated
26/06/2026
Date data sharing statement initially provided
Help: Data sharing statement date
26/06/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
Robotic colorectal and abdominal wall surgery using the Toumai® MT-1000 surgical robot: a feasibility and safety study at Concord Repatriation General Hospital (PROCord)
Scientific title
Prospective Clinical Trial in Robotic Colorectal and Complex Abdominal Wall Reconstructive Surgeries using Toumai® Surgical Robot (PROCord): a single-centre feasibility and safety study evaluating intraoperative conversion rate and perioperative outcomes in adult patients undergoing elective robotic-assisted procedures at Concord Repatriation General Hospital
Additional trial identifiers [1] 317338 0
Nil Known
Universal Trial Number (UTN)
Trial acronym
Related trial records

Health condition
Health condition(s) studied:
Colorectal Cancer 341993 0
Diverticular Disease 341994 0
Inflammatory Bowel Disease 341995 0
Rectal prolapse 341996 0
Abdominal wall hernia 341997 0
Condition category
Condition code
Cancer 338074 338074 0 0
Bowel - Back passage (rectum) or large bowel (colon)
Oral and Gastrointestinal 338075 338075 0 0
Inflammatory bowel disease
Surgery 338076 338076 0 0
Surgical techniques

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
Participants undergo their planned, clinically-indicated colorectal or abdominal wall reconstructive procedure performed using the Toumai® MT-1000 robotic surgical system (MicroPort MedBot; ARTG ID 487874), on loan to Concord Repatriation General Hospital for 12 months.

How the system is used: The Toumai® MT-1000 is a master–slave robotic surgical system comprising a surgeon console, a patient-side cart with multiple interactive robotic arms holding interchangeable EndoWrist-style articulating instruments, and a 3D high-definition endoscope. After the patient is positioned and anaesthetised, pneumoperitoneum is established and laparoscopic ports are placed; the patient-side cart is docked and the robotic arms connected to the ports. The operating surgeon controls the instruments and camera remotely from the console while a bedside assistant exchanges instruments and provides retraction. Dissection, vessel division, bowel resection, anastomosis and/or hernia repair are performed robotically; the cart is then undocked for specimen retrieval and closure.

Eligible procedures (each performed as a single robotic operative episode): right/extended right, left and sigmoid colectomy; anterior and low anterior resection; subtotal colectomy; total proctocolectomy; abdominoperineal resection; total mesorectal excision with or without lateral pelvic lymph node dissection; reversal of Hartmann's; ventral rectopexy; robotic trans-anal minimally invasive surgery (TAMIS); and ventral/incisional/parastomal hernia repair with or without transversus abdominis release / component separation (including extended totally extraperitoneal [eTEP] repair).

Approximate duration: each procedure is a single operative episode of approximately [[surgery duration — e.g. "2 to 6 hours depending on procedure complexity"]].

Procedures are delivered by surgeons who are credentialled da Vinci Xi users and who complete Toumai-specific training plus a minimum of five proctored cases — assessed using the Global Evaluative Assessment of Robotic Skills (GEARS) tool — before operating independently. Surgical indications, technique and peri-operative care are otherwise unchanged from standard practice.

Adherence monitoring: Adherence to the intervention is monitored via a peri-operative data collection form completed in REDCap at the conclusion of each procedure, the standard operation report in the medical record, and review of GEARS assessments during the proctored phase. Participants are followed for 6 months. Target enrolment is 30 participants (25 colorectal, 5 abdominal wall).
Intervention code [1] 334234 0
Treatment: Surgery
Description of the comparator or control
Propensity score–matched historical cohort of patients who underwent equivalent colorectal cancer procedures by laparoscopic surgery at the same institution, drawn from the Concord Colorectal Cancer Database (HREC/16/CRGH/263). There is no prospective control arm. The time period would be cases collected over the period January 2016 to December 2025,
Control group
Historical

Outcomes
Primary outcome [1] 345605 0
Feasibility
Timepoint [1] 345605 0
Recorded intraoperatively at the end of each procedure; cumulative rate assessed at the interim analysis (first 10 participants) and at study completion (n=30).
Primary outcome [2] 345606 0
Safety
Timepoint [2] 345606 0
Assessed across the index admission (surgery to discharge), with further complication review at 6 weeks post-op; cumulative rate assessed at the interim analysis (first 10 participants) and at study completion.
Secondary outcome [1] 462360 0
Length of hospital stay
Timepoint [1] 462360 0
At hospital discharge
Secondary outcome [2] 462361 0
Estimated blood loss
Timepoint [2] 462361 0
At the end of the procedure
Secondary outcome [3] 462364 0
Console time
Timepoint [3] 462364 0
At the end of the procedure
Secondary outcome [4] 462365 0
Docking time
Timepoint [4] 462365 0
At the end of the procedure
Secondary outcome [5] 462366 0
Blood transfusion
Timepoint [5] 462366 0
At the end of the procedure
Secondary outcome [6] 462367 0
Quality of life
Timepoint [6] 462367 0
Before surgery, 6-weeks after surgery, 3-months and 6-months after surgery
Secondary outcome [7] 462368 0
Clinician experience
Timepoint [7] 462368 0
At conclusion of the study
Secondary outcome [8] 462369 0
Learning curve
Timepoint [8] 462369 0
At the end of the procedure
Secondary outcome [9] 462370 0
In-hospital cost
Timepoint [9] 462370 0
At hospital discharge

Eligibility
Key inclusion criteria
Patient participants: adults aged 18 years or older; undergoing an elective colorectal or abdominal wall reconstructive procedure; clinically suitable for a robotic approach; able to provide written informed consent. All genders eligible; both public and private patients eligible regardless of Medicare or insurance status.

Health-professional participants (experience survey): any clinician — including surgeons, anaesthetists and theatre nurses — present in theatre for a Toumai® MT-1000 procedure during the trial.
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
1. Cannot consent — the patient is unable to provide written informed consent for themselves.

2. Unsuitable for robotic-assisted surgery on clinical assessment, defined as one or more of:

a. haemodynamic instability precluding prolonged pneumoperitoneum;
b. prior major abdominal surgery with extensive adhesions judged likely to prevent safe robotic access;
c. body habitus or anatomical factors incompatible with safe robotic positioning;
d. emergency or urgent surgical presentation.

Study design
Purpose of the study
Treatment
Allocation to intervention
Non-randomised trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Single group
Other design features
Phase
Not Applicable
Type of endpoint/s
Safety
Statistical methods / analysis
The study will use simple descriptive statistics to summarise patient characteristics and surgical results, including safety and whether the operation could be completed robotically as planned. Operating time will be tracked across cases to understand the learning curve for the new robotic system. All analyses are exploratory because this is an early safety and feasibility study and is not designed to test effectiveness.

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
NSW

Funding & Sponsors
Funding source category [1] 321908 0
Government body
Name [1] 321908 0
Sydney Local Health District
Country [1] 321908 0
Australia
Primary sponsor type
Government body
Name
Sydney Local Health District
Address
Country
Australia
Secondary sponsor category [1] 324770 0
None
Name [1] 324770 0
Address [1] 324770 0
Country [1] 324770 0

Ethics approval
Ethics application status
Submitted, not yet approved
Ethics committee name [1] 320444 0
Sydney Local Health District HREC – Concord Repatriation General Hospital
Ethics committee address [1] 320444 0
Ethics committee country [1] 320444 0
Australia
Date submitted for ethics approval [1] 320444 0
30/03/2026
Approval date [1] 320444 0
Ethics approval number [1] 320444 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 150506 0
Dr Henry Cheung
Address 150506 0
Colorectal Outpatient Department, Concord Repatriation General Hospital Medical Centre, Level 1, Suite 102, Hospital Road, COncord NSW 2139
Country 150506 0
Australia
Phone 150506 0
+61 29767 7950
Fax 150506 0
Email 150506 0
Contact person for public queries
Name 150507 0
Henry Cheung
Address 150507 0
Colorectal Outpatient Department, Concord Repatriation General Hospital Medical Centre, Level 1, Suite 102, Hospital Road, COncord NSW 2139
Country 150507 0
Australia
Phone 150507 0
+61 29767 7950
Fax 150507 0
Email 150507 0
Contact person for scientific queries
Name 150508 0
Henry Cheung
Address 150508 0
Colorectal Outpatient Department, Concord Repatriation General Hospital Medical Centre, Level 1, Suite 102, Hospital Road, COncord NSW 2139
Country 150508 0
Australia
Phone 150508 0
+61 29767 7950
Fax 150508 0
Email 150508 0

Data sharing statement
Will the study consider sharing individual participant data?
Yes
Will there be any conditions when requesting access to individual participant data?
Persons/groups eligible to request access:
• Researchers
Conditions for requesting access:
• Yes, conditions apply:
• Requires review on a case-by-case basis by the trial custodian, sponsor or data sharing committee
• Requires a scientifically sound proposal or protocol
• Requires approval by an ethics committee
• Requires a data sharing agreement between data requester and trial custodian or sponsor
What individual participant data might be shared?
• De-identified individual participant data:
• All outcomes data
• Published results
• Primary outcome(s)
• Safety data
What types of analyses could be done with individual participant data?
• Any type of analysis (i.e. no restrictions on data re-use)
When can requests for individual participant data be made (start and end dates)?
From:
At the end of the study
To:
Not yet decided
Where can requests to access individual participant data be made, or data be obtained directly?
• Email of trial custodian, sponsor or committee: [email protected]

Are there extra considerations when requesting access to individual participant data?
Yes: Institutional data sharing policies at the discretion of the LHD



What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.